Dimensional Fund Advisors LP Has $130.05 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Dimensional Fund Advisors LP lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 21.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,851,869 shares of the medical instruments supplier's stock after purchasing an additional 1,230,944 shares during the quarter. Dimensional Fund Advisors LP owned approximately 3.45% of DENTSPLY SIRONA worth $130,045,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Pacer Advisors Inc. grew its stake in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Nuance Investments LLC raised its stake in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $45,730,000. Cooke & Bieler LP boosted its stake in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares during the period. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded up $0.12 during mid-day trading on Monday, hitting $13.87. 2,260,426 shares of the company's stock were exchanged, compared to its average volume of 2,970,223. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -6.70, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The stock's 50-day simple moving average is $14.99 and its 200-day simple moving average is $18.17. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $31.00.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.61%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th. Barrington Research lowered their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Evercore ISI reissued an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Finally, Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Thirteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus target price of $22.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.